BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 6760876)

  • 1. [Interpretation of minimal medullary plasmacytoses in monoclonal dysglobulinemias. Importance of the study of osteomedullary biopsies of semi-thin sections and immunologic marking].
    Canioni D; Kermarec J
    Ann Pathol; 1982; 2(4):279-92. PubMed ID: 6760876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neural cell adhesion molecule expression in plasma cells in bone marrow biopsies and aspirates allows discrimination between multiple myeloma, monoclonal gammopathy of uncertain significance and polyclonal plasmacytosis.
    Martín P; Santón A; Bellas C
    Histopathology; 2004 Apr; 44(4):375-80. PubMed ID: 15049904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunosecretory cells in human bone marrow. Immunofluorescence study on histological sections].
    Chomette G; Sevestre C; Gregeois J
    Ann Anat Pathol (Paris); 1977; 22(3):209-19. PubMed ID: 417647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Contribution of bone biopsy with histomorphometry in the evaluation of monoclonal gammopathy].
    Alexandre C; Bataille R; Chappard D; Dessauw P; Sany J; Riffat G
    Rev Rhum Mal Osteoartic; 1987 Nov; 54(11):717-21. PubMed ID: 3423714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin secretion by peripheral blood and bone marrow B cells in patients with multiple myeloma. Studies by the reverse haemolytic plaque assay.
    Dammacco F; Vacca A; Altomare E; Campobasso N
    Clin Exp Immunol; 1984 Sep; 57(3):743-51. PubMed ID: 6380841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel type of proliferating lymphoplasmacytoid cell with a characteristic spotted immunofluorescence pattern.
    Lokhorst HM; Boom SE; Bast BJ; Peters PJ; Tedder TF; Gerdes J; Petersen E; Ballieux RE
    J Clin Invest; 1987 May; 79(5):1401-11. PubMed ID: 3553239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should bone marrow examination be routinely performed for the diagnosis of monoclonal gammopathy of undetermined significance?
    Elis A; Radnay J; Shapiro H; Itzhaky D; Manor Y; Lishner M
    Isr Med Assoc J; 2006 Dec; 8(12):840-2. PubMed ID: 17214099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow biopsy in multiple myeloma: a clinical pathological study.
    Aghai E; Avni G; Lurie M; Quitt M; Hornstein L; Froom P
    Isr J Med Sci; 1988 Jun; 24(6):298-301. PubMed ID: 3403226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of monoclonal gammopathy of undetermined significance and multiple myeloma using flow cytometric characteristics of plasma cells.
    Sezer O; Heider U; Zavrski I; Possinger K
    Haematologica; 2001 Aug; 86(8):837-43. PubMed ID: 11522540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow percentage of plasma cells in the staging of monoclonal gammopathies.
    Vercelli D; Di Guglielmo R; Guidi G; Scolari L; Buricchi L; Cozzolino F
    Nouv Rev Fr Hematol (1978); 1980; 22(2):139-45. PubMed ID: 7422542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow aspirate immunofluorescent and bone marrow biopsy immunoperoxidase staining of plasma cells in histologically occult plasma cell proliferative marrow disorders.
    Menke DM; Greipp PR; Colon-Otero G; Solberg LA; Cockerill KJ; Hook CC; Witzig TE
    Arch Pathol Lab Med; 1994 Aug; 118(8):811-4. PubMed ID: 7520228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [IgM myeloma. Apropos of a case].
    Heron JF; Guaydier G; Loyau G; Laniece M; Mandart JC; Borel B; L'Hirondel JL; Dumas M; Foucault JP
    Sem Hop; 1976 Dec; 52(44):2549-52. PubMed ID: 188198
    [No Abstract]   [Full Text] [Related]  

  • 13. The laboratory diagnosis of plasma cell myeloma and related disorders.
    Nawab RA; Azar HA
    Orthop Clin North Am; 1979 Apr; 10(2):391-404. PubMed ID: 109804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B lymphocyte markers in multiple myeloma and related plasma cell dyscrasias.
    Ricci C; Coscia G; Bozzone DM; Canavera RM; Baldassi R; Cascio G; Anania A; Marchi L; Verney MM
    Cancer Detect Prev; 1988; 11(3-6):423-32. PubMed ID: 3260538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cytological study of acid phosphatase activity of plasma cells in monoclonal gammopathies].
    Ricci C; Coscia GG; Bellone G; Novarini M; Discalzi GL; Cascio G
    Acta Med Austriaca; 1984; 11(2):37-43. PubMed ID: 6741437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial bone marrow findings in multiple myeloma. Significance of plasma cell nodules.
    Buss DH; Prichard RW; Hartz JW; Cooper MR; Feigin GA
    Arch Pathol Lab Med; 1986 Jan; 110(1):30-3. PubMed ID: 3753566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ["Benign" monoclonal gammopathy: prognostic value of initial bone marrow study].
    Grau E; Ayats R; Puig J; Domingo A; Pujol-Moix N
    Sangre (Barc); 1985; 30(3):308-19. PubMed ID: 4035526
    [No Abstract]   [Full Text] [Related]  

  • 18. [IgM monoclonal gammopathy in plasmacytic neoplasms].
    Kraj M; Kopeć I; Rostkowska J; Pogłód R; Maj S
    Acta Haematol Pol; 1990; 21(2):153-65. PubMed ID: 2131715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histomorphology of multiple myeloma on bone marrow biopsy.
    Singhal N; Singh T; Singh ZN; Shome DK; Gaiha M
    Indian J Pathol Microbiol; 2004 Jul; 47(3):359-63. PubMed ID: 16295424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and prognostic value of the MB2 monoclonal antibody in paraffin-embedded bone marrow sections of patients with multiple myeloma and monoclonal gammopathy of undetermined significance.
    Dehou MF; Schots R; Lacor P; Arras N; Verhavert P; Klöppel G; van Camp B
    Am J Clin Pathol; 1990 Sep; 94(3):287-91. PubMed ID: 1697732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.